Evaluating glomerular filtration rate slope as a surrogate endpoint for ESKD in clinical trials: an individual participant meta-analysis of observational data
<br/><strong>Background: </strong>Decline in eGFR is a biologically plausible surrogate end point for the progression of CKD in clinical trials. However, it must first be tested to ensure strong associations with clinical outcomes in diverse populations, including patients with hig...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Society of Nephrology
2019
|